APA (7th ed.) Citation

Yanni Hao, Wei-Chun Hsu, Craig S Parzynski, Evgeny Degtyarev, Lisa V Hampson, Aisha Masood, & Wen-Hsing Wu. (2023). Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma. Becaris Publishing Limited.

Chicago Style (17th ed.) Citation

Yanni Hao, Wei-Chun Hsu, Craig S Parzynski, Evgeny Degtyarev, Lisa V Hampson, Aisha Masood, and Wen-Hsing Wu. Effectiveness of Tisagenlecleucel Versus Real-world Standard of Care in Relapsed/refractory Follicular Lymphoma. Becaris Publishing Limited, 2023.

MLA (9th ed.) Citation

Yanni Hao, et al. Effectiveness of Tisagenlecleucel Versus Real-world Standard of Care in Relapsed/refractory Follicular Lymphoma. Becaris Publishing Limited, 2023.